MIR6760

Across TCGA pan-cancer cohorts, MIR6760 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated MIR6760 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher MIR6760 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated MIR6760 expression acts as an unfavorable survival marker, although some lineages such as OV show a favorable association.

OV, ACC, and BRCA are the cancer types where MIR6760 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Tertile	All	0.675	0.372	.015	66	view →
ACC	OS	Tertile	All	0.133	0.686	.004	54	view →
BRCA	DFS	Tertile	All	0.181	0.529	.005	18	view →
BLCA	DFS	Tertile	All	0.159	0.625	.040	18	view →
LAML	DFS	Tertile	All	0.184	0.484	.036	18	view →
LIHC	DFS	Tertile	All	0.100	0.526	.038	18	view →
ESCA	OS	Tertile	All	0.306	0.684	.036	9	view →
SARC	DFS	Tertile	All	0.127	0.611	.049	9	view →
PRAD	OS	Tertile	All	0.984	0.995	.046	6	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

MIR6760–OV (DFS)

Open the OV breakdown →